These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 24872692

  • 1. Effective mucoadhesive liposomal delivery system for risedronate: preparation and in vitro/in vivo characterization.
    Jung IW, Han HK.
    Int J Nanomedicine; 2014; 9():2299-306. PubMed ID: 24872692
    [Abstract] [Full Text] [Related]

  • 2. Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system.
    Han HK, Shin HJ, Ha DH.
    Eur J Pharm Sci; 2012 Aug 15; 46(5):500-7. PubMed ID: 22522117
    [Abstract] [Full Text] [Related]

  • 3. Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome.
    Qiang F, Shin HJ, Lee BJ, Han HK.
    Int J Pharm; 2012 Jul 01; 430(1-2):161-6. PubMed ID: 22525082
    [Abstract] [Full Text] [Related]

  • 4. TPGS-chitosome as an effective oral delivery system for improving the bioavailability of Coenzyme Q10.
    Shao Y, Yang L, Han HK.
    Eur J Pharm Biopharm; 2015 Jan 01; 89():339-46. PubMed ID: 25542680
    [Abstract] [Full Text] [Related]

  • 5. Ionic complex of risedronate with positively charged deoxycholic acid derivative: evaluation of physicochemical properties and enhancement of intestinal absorption in rats.
    Park JW, Byun Y.
    Arch Pharm Res; 2014 Dec 01; 37(12):1560-9. PubMed ID: 24254935
    [Abstract] [Full Text] [Related]

  • 6. Enhanced oral absorption of sorafenib via the layer-by-layer deposition of a pH-sensitive polymer and glycol chitosan on the liposome.
    Zhao M, Lee SH, Song JG, Kim HY, Han HK.
    Int J Pharm; 2018 Jun 10; 544(1):14-20. PubMed ID: 29655795
    [Abstract] [Full Text] [Related]

  • 7. N-trimethyl chitosan-modified liposomes as carriers for oral delivery of salmon calcitonin.
    Huang A, Makhlof A, Ping Q, Tozuka Y, Takeuchi H.
    Drug Deliv; 2011 Nov 10; 18(8):562-9. PubMed ID: 21823926
    [Abstract] [Full Text] [Related]

  • 8. Properties of liposomes coated with hydrophobically modified chitosan in oral liposomal drug delivery.
    Thongborisute J, Takeuchi H, Yamamoto H, Kawashima Y.
    Pharmazie; 2006 Feb 10; 61(2):106-11. PubMed ID: 16526556
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs.
    Takeuchi H, Matsui Y, Sugihara H, Yamamoto H, Kawashima Y.
    Int J Pharm; 2005 Oct 13; 303(1-2):160-70. PubMed ID: 16125348
    [Abstract] [Full Text] [Related]

  • 10. Chemical coupling of thiolated chitosan to preformed liposomes improves mucoadhesive properties.
    Gradauer K, Vonach C, Leitinger G, Kolb D, Fröhlich E, Roblegg E, Bernkop-Schnürch A, Prassl R.
    Int J Nanomedicine; 2012 Oct 13; 7():2523-34. PubMed ID: 22679365
    [Abstract] [Full Text] [Related]

  • 11. Liposomes coated with N-trimethyl chitosan to improve the absorption of harmine in vivo and in vitro.
    Chen WL, Yuan ZQ, Liu Y, Yang SD, Zhang CG, Li JZ, Zhu WJ, Li F, Zhou XF, Lin YM, Zhang XN.
    Int J Nanomedicine; 2016 Oct 13; 11():325-36. PubMed ID: 26855571
    [Abstract] [Full Text] [Related]

  • 12. Improvement of bone microarchitecture in methylprednisolone induced rat model of osteoporosis by using thiolated chitosan-based risedronate mucoadhesive film.
    Mukherjee D, Srinivasan B, Anbu J, Azamthulla M, Banala VT, Ramachandra SG.
    Drug Dev Ind Pharm; 2018 Nov 13; 44(11):1845-1856. PubMed ID: 30028215
    [Abstract] [Full Text] [Related]

  • 13. Mucoadhesive chitosan-coated liposomes: characteristics and stability.
    Filipović-Grcić J, Skalko-Basnet N, Jalsenjak I.
    J Microencapsul; 2001 Nov 13; 18(1):3-12. PubMed ID: 11201339
    [Abstract] [Full Text] [Related]

  • 14. Polymer coated liposomes for use in the oral cavity - a study of the in vitro toxicity, effect on cell permeability and interaction with mucin.
    Klemetsrud T, Kjøniksen AL, Hiorth M, Jacobsen J, Smistad G.
    J Liposome Res; 2018 Mar 13; 28(1):62-73. PubMed ID: 27809639
    [Abstract] [Full Text] [Related]

  • 15. Formulation and evaluation of a folic acid receptor-targeted oral vancomycin liposomal dosage form.
    Anderson KE, Eliot LA, Stevenson BR, Rogers JA.
    Pharm Res; 2001 Mar 13; 18(3):316-22. PubMed ID: 11442271
    [Abstract] [Full Text] [Related]

  • 16. Thiomer-coated liposomes harbor permeation enhancing and efflux pump inhibitory properties.
    Gradauer K, Dünnhaupt S, Vonach C, Szöllösi H, Pali-Schöll I, Mangge H, Jensen-Jarolim E, Bernkop-Schnürch A, Prassl R.
    J Control Release; 2013 Feb 10; 165(3):207-15. PubMed ID: 23228848
    [Abstract] [Full Text] [Related]

  • 17. The effect of particle structure of chitosan-coated liposomes and type of chitosan on oral delivery of calcitonin.
    Thongborisute J, Tsuruta A, Kawabata Y, Takeuchi H.
    J Drug Target; 2006 Apr 10; 14(3):147-54. PubMed ID: 16753828
    [Abstract] [Full Text] [Related]

  • 18. Optimization, cellular uptake, and in vivo evaluation of Eudragit S100-coated bile salt-containing liposomes for oral colonic delivery of 5-aminosalicylic acid.
    Alghurabi H, Jassim Muhammad H, Tagami T, Ogawa K, Ozeki T.
    Int J Pharm; 2023 Dec 15; 648():123597. PubMed ID: 37952559
    [Abstract] [Full Text] [Related]

  • 19. Anionic versus cationic bilosomes as oral nanocarriers for enhanced delivery of the hydrophilic drug risedronate.
    Elnaggar YSR, Omran S, Hazzah HA, Abdallah OY.
    Int J Pharm; 2019 Jun 10; 564():410-425. PubMed ID: 31029657
    [Abstract] [Full Text] [Related]

  • 20. Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers.
    Huang A, Su Z, Li S, Sun M, Xiao Y, Ping Q, Deng Y.
    Drug Deliv; 2014 Aug 10; 21(5):388-96. PubMed ID: 24188463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.